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Abstract
Background: Cancer stem cells (CSCs) play an important role in tumor initiation, progression, and metastasis and are
responsible for high therapeutic failure rates. Identification and characterization of CSC are crucial for facilitating the
monitoring, therapy, or prevention of cancer. Great efforts have been paid to develop a more effective methodology.
Nevertheless, the ideal model for CSC research is still evolving. In this study, we created a nonadhesive culture system to
enrich CSCs from human oral squamous cell carcinoma cell lines with sphere formation and to characterize their CSC
properties further.
Methods: A nonadhesive culture system was designed to generate spheres from the SAS and OECM-1 cell lines. A
subsequent investigation of their CSC properties, including stemness, self-renewal, and chemo- and radioresistance in vitro,
as well as tumor initiation capacity in vivo, was also performed.
Results: Spheres were formed cost-effectively and time-efficiently within 5 to 7 days. Moreover, we proved that these
spheres expressed putative stem cell markers and exhibited chemoradiotherapeutic resistance, in addition to tumor-
initiating and self-renewal capabilities.
Conclusions: Using this nonadhesive culture system, we successfully established a rapid and cost-effective model that
exhibits the characteristics of CSCs and can be used in cancer research.
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Introduction
Oral squamous cell carcinoma (OSCC) is one of the most
common and lethal head and neck malignancies in Taiwan and
worldwide [1,2]. OSCC is a disease that is difficult to treat because
of the diverse treatment strategies available and the variable
natural behavior of the cancer. Local invasion and frequent
regional lymph node metastases, together with relative resistance
to chemotherapeutic drugs, lead to an unpredictable outcome [2–
4]. Despite increased experience in surgical technology and
adjuvant treatments, the overall prognoses of OSCC remain
unimproved, resulting in the urgent need of a novel strategy for
OSCC treatment [3,5].
Substantial evidences from recent studies show that solid tumors
contain a subpopulation of cancer stem cells (CSCs) [6–8]. It is
well known that CSCs play an important role in tumor initiation,
progression, metastasis, and therapeutic resistance [9–11]. How-
ever, the putative CSCs from OSCC have not been well
characterized. It is hypothesized that CSCs possess several
characteristics that make them resistant to conventional chemo-
and radiotherapy, including high expression of drug transporters,
relative cell-cycle quiescence, high function of DNA repair
machinery, and resistance to apoptosis [12,13]. The identification
and characterization of CSCs from OSCC are crucial for
facilitating the monitoring, treatment, and prevention of the
disease.
The isolation of CSCs from cancer cells has been achieved
successfully via the use of different techniques. The isolation of
CSCs is performed using flow cytometry based on the expression
of specific cell surface markers, such as CD133, CD44 and
ALDH1, by CSCs [14–20]. Because of the therapeutic resistance
of CSCs, sorting the side populations of cancer cells via
intracellular Hoechst 33342 exclusion or selecting chemothera-
peutic-drug-resistant cells has also been used for the identification
and characterization of CSCs [21–23]. Concurrent studies
confirmed that the sphere culture system is as efficient in
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These studies have suggested that CSCs can be enriched in
spheres when these are cultured in serum-free medium supple-
mented with adequate mitogens, such as the basic fibroblast
growth factor (bFGF) and epidermal growth factor (EGF) [11,24–
26]. However, the derivation of CSCs from solid tumors and
cancer cell lines cultured in serum-free medium supplemented
with bFGF and EGF is a time-consuming process and 2–6 weeks
are needed for sphere formation [11,24–26]. Furthermore, the
selected growth factors, such as the platelet-derived growth factor,
bFGF, and EGF, are costly and ineffective. To overcome these
drawbacks and limitations, we used a purpose-designed nonadhe-
sive sphere culture system to identify and enrich CSCs from
established human OSCC cell lines, and to characterize their CSC
properties further using phenotypic/genotypic characterization.
Results
The sphere formation from human OSCC cell lines
OSCC cell lines (SAS and OECM-1) were gently dissociated
into single cells and seeded into culture plastic wares with a
nonadhesive coating, as shown in Figure 1. Part of the suspension
of cells may undergo apoptosis during the first 2 days when
cultured in a nonadhesive, suspended environment. Some of the
suspended cells aggregated and then merged and differentiated
into three-dimensional (3D) balls with a spheroid configuration.
The subsequent morphological alteration (,3–5 days) consisted of
floating spheres. After 5–7 days of culture, spheres with a round
and smooth contour were observed. These spheres grew gradually
over time (Figure 1A). Morphologically, the spheres appeared
more tightly attached, clustering or overlapping in a 3D
configuration, compared with those observed in the parental cells.
One previous study suggested that the derivation of spheres from
cancer cell lines or primary culture cells may accompany the
alteration of phenotypic/genotypic characteristics, such as the
epithelial–mesenchymal transition (EMT) [27]. The representative
EMT markers E-cadherin and fibronectin were chosen to identify,
and compare the differences between, the parental cells and
spheres in OECM-1 and SAS cells. Microscopic examination of
immunohistochemically stained parental cells and spheres showed
the presence of generalized and diffuse expression of E-cadherin
and sparse expression of fibronectin in parental cells, whereas
spheres exhibited loss of expression of E-cadherin and overex-
pression of fibronectin (Figure 1B).
Expression of putative stem cell surface markers
To elucidate whether spheres could enrich cells expressing
putative cancer stem cell markers, we chose to analyze the
Figure 1. The sphere formation from human OSCC cell lines. (A) Phase-contrast photomicrographs of the spheres cultured from SAS (top) and
OECM-1 (bottom) cell lines using a nonadhesive design (four leftmost upper and lower panels: from day 0 to day 7, magnification, 2006; and
rightmost upper lower panels: day 10, magnification, 1006). (B) Immunohistochemistry results showing diverse expression patterns of representative
epithelial–mesenchymal transition (EMT) markers in OECM1 parental cells and spheres (magnification, 2006).
doi:10.1371/journal.pone.0031864.g001
Rapid Culture Model of Sphere with CSC Properties
PLoS ONE | www.plosone.org 2 February 2012 | Volume 7 | Issue 2 | e31864expression profile of two representative stem cell surface markers
of OSCC, CD133 and ALDH1 [11,14–18]. As shown in Figure 2A
and B, the parental cells and spheres (after 7 days of nonadhesive
culture) were positively stained for CD133 and ALDH1.
Expression of CD133 and ALDH1 was usually absent or very
low in parental cells. We detected a 3–4% increase in CD133
expression and a 20–30% increase in ALDH1 expression in
spheres compared with parental cells. The levels of expression of
CD133 and ALDH1 were significantly higher in spheres than they
were in parental cells (Figure 2C).
Expression of cancer stem cell genes and related proteins
The expression of stem cell genes and related proteins, including
SOX2, Oct4, and NANOG, was examined at the transcriptional and
translational levels. Total RNA was purified from parental cells
and spheres after 7 days of nonadhesive culture. The levels of
SOX2, Oct4, and NANOG transcripts were significantly
increased in spheres compared with parental cells, as assessed
using reverse transcription PCR analysis (Figure 3A). Western
blotting data showed that the expression of the SOX2, Oct4, and
NANOG proteins was also upregulated in spheres compared with
parental cells (Figure 3B). Furthermore, we used immunofluores-
cence staining to assess the cellular levels of CD133, ALDH1,
SOX2, Oct4, and NANOG in spheres. We observed diverse
expression patterns for these proteins, as indicated in Figure 3C,
which suggests the heterogeneity of OSCC. CD133 was expressed
in the cell membrane and ALDH1 was expressed in the cell
membrane and cytoplasm, whereas SOX2, Oct4, and NANOG
were expressed in the nucleus.
Radio- and chemosensitivity
To assess the radiosensitivity of the parental cells and spheres,
we treated these cells and spheres with radiation doses up to 10 Gy
to evaluate cell viability, which was measured using an MTS assay
after 36 h of radiation treatment. Spheres were more radioresis-
tant than parental cells (Figure 4A). We also examined the
chemosensitivity of the parental cells and spheres using cisplatin.
Parental cells and spheres were treated with cisplatin for 48 h and
cell viability was measured subsequently using an MTS assay
(Figure 4B). Spheres were more resistant to cisplatin than parental
cells. To imitate the clinical condition, we administered a
combined chemo- and radiotherapy (CCRT) treatment, with (1)
initial chemotherapy consisting of 20 mM cisplatin for 24 h
followed by radiation (Figure 4C) or (2) initial radiation followed
by chemotherapy using 20 mM cisplatin for 24 h (Figure 4D). The
results of treatment using these two CCRT regimens revealed that
the combinations were more effective in reducing the survival rate
of the parental cells and spheres compared with single treatment of
Figure 2. Comparison of the expression of specific surface markers of CSCs between parental cells and spheres. (A) The parental cells
and spheres were either stained with a negative-control IgG antibody (open space) or anti-CD133 experimental antibodies (solid space). (B)
Comparison of the expression of ALDH1 between parental cells and spheres; DEAB, an inhibitor of ALDH1, was used as a negative control. (C)
Quantitative and statistical comparisons of the percentage of positive signals for CD133 and ALDH1 between parental cells and spheres (*P,0.05).
doi:10.1371/journal.pone.0031864.g002
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expression of the SOX2, Oct4, and NANOG genes was upregulated in spheres compared with parental cells. (B) Western blotting analysis showed that
the expression of SOX2, Oct4, and NANOG was upregulated in spheres compared with parental cells. (C) Immunofluorescence analysis of CSC markers
in spheres demonstrated the presence of CSCs with variable levels of expression of CD133, ALDH1, SOX2, Oct4, and NANOG, as indicated by the
arrows (magnification, 2006).
doi:10.1371/journal.pone.0031864.g003
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resistant than the parental cells (with variable significance levels)
when using the combined treatment.
In vivo tumorigenicity
To confirm the enriched tumor-initiating capabilities of spheres
in vivo, both parental cells and spheres were injected into nude
mice, for analysis of transplanted tumorigenicity. Spheres derived
from SAS cells gave rise to tumors when 1610
5 cells were injected
into mice (two out of three mice), and spheres derived from
OECM-11 cells generated tumors when only 1610
4 cells were
injected into mice (one out of three mice). In contrast, 1610
6
parental cells were needed to generate tumors, suggesting that
spheres were enriched for tumor-initiating cells by at least 10- to
100-fold compared with parental cells (Table 1). A comparative
analysis of gross appearance between the tumors newly generated
from parental cells and spheres revealed the presence of significant
differences regarding size and contour. Spheres yielded tumors of
a much larger size with an irregular, expansible contour compared
with the tumors generated by parental cells (Figure 5A). A
comparative analysis of the corresponding histological and
immunohistochemical results for representative EMT markers
showed that tumors derived from spheres appeared to be more
aggressive and have a mesenchymal-like appearance and prom-
inent stromal invasion compared with the tumors derived from
parental cells. We observed uneven expression of E-cadherin in
tumors derived from parental cells and a loss of E-cadherin
expression in tumors derived from spheres. There was an obvious
overexpression of fibronectin in tumors derived from spheres
compared with tumors derived from parental cells (Figure 5B).
Primary cultures prepared from the resection of tumors induced
by spheres in NOD/SCID mice demonstrated a gradual
transformation of primary and secondary sphere formation,
suggesting that spheres have a powerful capacity for self-renewal
(Figure 5C).
Discussion
The concept of CSCs and their applications have been reported
in recent decades. The term ‘‘cancer stem cell’’ was defined in
2006 by the American Association for Cancer Research Workshop
on Cancer Stem Cells as a cell within a tumor that possesses the
capacity to self-renew and to generate the heterogeneous lineages
of cancer cells that comprise the tumor [6]. A review of the
literature demonstrated that CSCs were first isolated by Bonnet
and Dijk in acute myeloid leukemia, and Al Hajj was the first to
identify them in solid tumors [28,29]. To date, CSCs have been
identified in many solid tumors, including brain, breast, lung,
prostate, and colon cancers [24,25,30–33].The CSC theory
clarifies not only the issue of tumor initiation, development,
metastasis, and relapse, but also the ineffectiveness of conventional
cancer therapies. According to current knowledge, the initiation,
recurrence, and metastasis of cancers may be explained, at least in
part, by the presence of CSCs [6–8,34]. Consequently, the
development of a reliable model of CSCs becomes crucial for basic
and clinical cancer research.
Several techniques have been used to isolate CSCs from cancers
(Table 2 and Figure S1). Initially, as the specific surface markers
CD34 and CD38 had been extensively validated in the
identification of normal hematopoietic stem cells, these molecules
were used as markers in the original studies of leukemia stem cells
[28]. Subsequently, CD24 and CD44 were selected as CSC
markers in breast tumors [29]. Nevertheless, currently there is no
apparent consensus regarding the ‘‘best marker(s)’’ to be used for
the identification of CSCs in any particular cancer. There are
some reports demonstrated that CD44 is a selective marker of
CSCs from HNSCC [19,20]. However, our data showed that
CD24 and CD44 were abundantly present in both parental cells
and spheres (up to 20–40%) (Figure S2). We selected two other
representative stem cell surface markers of OSCC, CD133 and
ALDH1, to detect the expression profile of both parental cells and
spheres [11,14–18]. The expression of CD133 and ALDH1 was
usually absent or very low in parental cells compared with higher
CD133 (3–4%) and ALDH1 (20–30%) expression in spheres.
Although the expression of CD133 and ALDH1 was significantly
higher in spheres than in parental cells, CD133 and ALDH1 were
relatively adequate CSC markers in OSCC, but were not
appropriate for the isolation of CSCs from the cancer proper
because of tumor heterogeneity and unpredictable reproducibility
(Figure S1A). The identification of specific surface marker(s) for
the identification of CSCs and therapeutic targets remains a
challenge. Sorting the side populations of cancer cells via
intracellular Hoechst 33342 exclusion and/or selecting the
chemotherapeutic-drug-resistant cells have also been used for the
identification and characterization of CSCs [21–23,31]. However,
the method of sorting the side populations via Hoechst 33342
exclusion yielded only a small number of CSCs (0.23–22.3%),
which is inadequate for further experimentation [21,22,31].
Recent studies showed that CSC selection via isolation of
chemotherapeutic-drug-resistant cells can provide a limited
number of CSCs (20–40%); however, the production of larger
amounts of CSCs was expensive and time consuming (Figure S1B)
[17]. Recent studies have also suggested that CSCs can be
enriched in spheres when cultured in serum-free medium
supplemented with adequate growth factors [11,24–26]. The
production of CSCs derived from OSCC cells cultured in serum-
free medium supplemented with bFGF and EGF was a long, time-
consuming, and cost-ineffective procedure for sphere formation
[11], as shown in the upper part of Figure S1C.
Previous studies revealed that many types of cells have been
described regarding the formation of 3D spheroids when cultured
Figure 4. Comparison of radio- and chemosensitivity between parental cells and spheres of the two cell lines. Significant differences in
(A) radiosensitivity and (B) chemosensitivity were observed between parental cells and spheres. (C) Combined chemo- and radiotherapy (CCRT) with
initial chemotherapy for 24 h followed by radiation. (D) CCRT with initial radiation followed by chemotherapy for 24 h. The two CCRT regimens were
more effective in reducing the survival rate of parental cells and spheres compared with single treatment using either radiation or chemotherapy
(*P,0.05).
doi:10.1371/journal.pone.0031864.g004
Table 1. Tumorgenicity of the parental cells and spheres.
Cell line SAS OECM1
Cell number for
injection parental cell sphere parental cell sphere
10
4 0/3 0/3 0/3 1/3
10
5 0/3 2/3 0/3 2/3
10
6 2/3 3/3 3/3 3/3
doi:10.1371/journal.pone.0031864.t001
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spheroids are widely used as study models for cancer metastasis
and invasion and for therapeutic screening; however, to the best to
our knowledge, none of them mentioned the properties of CSCs
[36–39]. In the current study, we first established a model of rapid
and adequate sphere formation from human OSCC cell lines.
Based on a nonadhesive culture system, this model was time
efficient because spheres were generated within 5 to 7 days
(Figure 1A). In addition, this modified nonadhesive culture system
is cost-effective and does not require growth factors compared with
the previous sphere culture system. It can not only successfully
enrich sphere formation from OSCC cell lines (SAS, OECM-1,
Figure 5. Comparison of newly generated tumors between OECM-1-derived parental cells and spheres in NOD/SCID mice. (A) Gross
appearance of a representative tumor formed by inoculation of parental cells and dissociated spheres into NOD/SCID mice (n=3 in each group). (B)
Corresponding histological findings and immunohistochemical results for representative EMT markers in NOD/SCID mice (magnification, 1006). (C)
Primary culture of dissociated cells from OECM-1-induced spheres originally isolated from NOD/SCID mice demonstrated a gradual transformation of
primary (1
st) and secondary (2
nd) spheres (magnification, 1006).
doi:10.1371/journal.pone.0031864.g005
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cancer cell lines from other parts of the head and neck (Fadu and
TW205), from the colon (HT29 and COLO320), and from the
lung (NCI-H23 and NCI-H661) (data not shown). Certain
evidence shows that sphere formation can be reached within 10–
15 days in serum-free medium supplemented with growth factors
[30,40]. However, these spheres are morphologically more likely
to be aggregates of grape-like bodies with irregular contour, and
not really spheres, as those seen in our study (Table 2 and Figure
S1). In our nonadhesive culture system, the spheres appeared
more tightly attached, ball-like, round, and smooth in contour.
Furthermore, the expression of representative cancer stem cell
genes and related proteins, including SOX2, Oct4, and NANOG,
was upregulated in spheres compared with those detected in
parental cells, at both the RNA and protein levels (Figures 3A and
B). Using immunofluorescence analysis, we demonstrated that
spheres exhibit explicit histological heterogeneity, as well as CSC
properties (Figure 3C). Evidence of enhanced therapeutic
resistance by CSCs, which is another major property of these
cells, has been reported. The phenomenon of recurrence of many
cancers after chemo- or radiotherapy can result from the survival
and maintenance of CSCs. In our study, we demonstrated that
spheres were more radio- and chemoresistant compared with
parental cells (Figure 4A and B). Because of the different origin
and characteristics of SAS and OECM-1 cells, there was a
different treatment outcome in these two types of cells. SAS cells
were more sensitive to chemotherapy, but more resistant to
radiation; in contrast, OECM-1 cells were more sensitive to
radiation, but more resistant to chemotherapy. CCRT was more
effective in reducing survival rate for both parental cells and
spheres compared with a single treatment with either radiation or
chemotherapy. Nevertheless, spheres were still more resistant than
parental cells when using the combined treatment. The use of this
nonadhesive culture system may provide a new insight and a new
model of CSCs that is applicable in therapeutic research.
Xenotransplantation studies can also help identify and confirm
the consecutively tumorigenic capability of nonadhesive culture
systems. Inoculation of both parental cells and spheres in NOD-
SCID mice generated new tumor(s) 7 days after implantation and
led to an increase in tumor size over time. A comparative analysis
showed that sphere-generated tumors exhibited a much larger size
with an irregular, expansible contour compared with those
generated by parental cells (Figure 5A). Based on primary culture
of the dissolved cells of sphere-generated tumors, which were
processed using the same protocols, primary and secondary
spheres were generated successfully, indicating their capacity for
self-renewal (Figure 5C). Interestingly, the corresponding histo-
logical and immunohistochemical results showed that tumors
derived from spheres exhibited a loss of E-cadherin and
upregulation of fibronectin, appeared to be more aggressive, and
had a mesenchymal-like appearance compared with tumors
derived from parental cells (Figure 5B).
As mentioned earlier, the enriched spheres cultured from
OSCC cell lines via a nonadhesive culture system may initially
become suspended and detached from the parental cells, and form
small clusters. Such spheres grown in a nonadhesive condition
subsequently exhibit reduced cell–cell or cell–matrix interactions,
lose their anchorage, and became homeless. This triggers a
phenomenon called ‘‘anoikis,’’ presumably resulting in apoptotic
response [41]. Floating spheres in a state of anoikis in the culture
medium are isolated and, although they attempt to adhere, are
unable to attach to the underlying or surrounding plate which are
expected to vanish in the end. How can these cancer cells survive
and proliferate to overcome the threat of anoikis? What
mechanism is involved in the acquisition of survival signals that
offer the ability to survive and proliferate in a floating tumor
population that lacks the normal solid-phase scaffolding, which
constitutes a challenged microenvironment? Several studies have
suggested that the adversity met by spheres in a nonadhesive,
suspended condition can be stimulated by EMT and also
encourage the enrollment of the potential of CSC properties
[42,43]. The literature also reveals that some signaling pathways
mediate EMT and CSC properties, such as WNT, Sonic
hedgehog, Snail/Slug, and NOTCH [44–46]. There is increasing
evidence suggesting that a link exists between EMT and CSCs that
involves cell morphology alteration and motility. These concepts
explain why our nonadhesive culture system can be used to enrich
CSCs from cancer cell lines.
In conclusion, using a modified nonadhesive culture system and
a subsequent series of experiments, we not only validated the CSC
properties of spheres isolated from OSCC cell lines, but also
successfully established a rapid and economic method that can
provide new insights and a newly applicable model for CSC
research.
Table 2. Comparison of the techniques in terms of isolation of CSCs related to time, cost, quantity and morphology.
Method Time Cost Efficiency of isolated CSC
Morphology of
isolated CSC References
sorting by specific CSCs surface
markers
nil moderate few
(2.5,50%)
nil [14–20,33]
sorting by side population cells nil moderate few
(0.23,22.3%)
nil [21,22]
selecting by chemotherapeutic
drug
4 weeks moderate moderate
(20,40%)
nil [23]
sphere culture via serum free
medium with growth factor
2,6 weeks high Many
(immeasurable)
sphere-like bodies [11,40]
sphere culture via serum free
medium with growth factor
10 to 15 days high Many
(immeasurable)
grapes-like bodies [24,26]
sphere culture via
non-adhesive culture system
5 to 7 days economic Abundant
(80 to 90%)
sphere formation current study
doi:10.1371/journal.pone.0031864.t002
Rapid Culture Model of Sphere with CSC Properties
PLoS ONE | www.plosone.org 8 February 2012 | Volume 7 | Issue 2 | e31864Materials and Methods
Cells
The human tongue cancer cell line SAS, obtained from the
Japanese Collection, was cultured in DMEM supplemented with
10% fetal bovine serum (FBS) at 37uC in the presence of 5% CO2.
The human gingival squamous carcinoma cell line with a p53
missens OECM-1, was cultured in RPMI1640 supplemented with
10% FBS at 37uC in the presence of 5% CO2. These two well
established cell lines were kindly provided by the Dr. Yi-Shing
Shieh from Department of Oral Diagnosis and Pathology, Tri-
Service General Hospital, Taipei, Taiwan [47].
Sphere culture
The two cell lines were cultured in culture plastic wares with
nonadhesive surface. 10 cm dish are made of nonadhesive for cells
by coating with agarose thin films. Cells were plated at a density of
5610
4 live cells/10 cm dish, and the culture medium was changed
every other day until the sphere formation.
Immunohistochemistry
Tissue sections or cell block were de-waxed in xylene and
rehydrated in alcohol. Antigen retrieval was carried out by
incubation in 10 mM citrate buffer (pH 6.0) at 95uC for 40 min.
Endogenous peroxidase was blocked with 0.3% hydrogen
peroxide for 10 min then incubated with 5% normal horse serum
in phosphate-buffered saline (PBS) for 60 min at room tempera-
ture to block non-specific antibody reaction. After a wash with
Tris-buffered saline plus 0.1% Tween 20(TBST), slides were
incubated overnight at 4uC with primary antibodies, E-cadher-
in(sc-8426; 1:800) and fibronetin (sc-18825; 1:500) (Santa Cruz
Biotechnology, Inc., CA. USA). After being rinsed in TBST, slides
were incubated for 30 min at room temperature with biotinylated
secondary antibody followed by streptavidin–biotinylated–enzyme
complex (streptABComplexes kit; Dako, Glostrup, Denmark).
Subsequently, they were stained with 0.003% 3,3-diaminobenzi-
dine tetrahydrochloride, counterstained with Mayer’s hematoxy-
lin, dehydrated, and mounted.
Flow cytometry
1610
6 single-cell suspension from trypsinized cells and spheres
were responded in 1 ml PBS and stained with CD133 (clone
C24B9, 1:200) (Cell Signaling Technology, Danvers, MA) and
aldehyde dehydrogenase 1 (ALDH1) (ALDEFLUOR assay kit;
StemCell Technologies, Durham, NC, USA). After labeling, the
cells were washed with PBS three times and subsequently stained
with FITC- or PE-labeled secondary antibody for 30 min in the
dark. The cells were analyzed on a flow cytometer after three
washes with PBS.
Reverse transcription-polymerase chain reaction (RT-PCR)
Total RNA was isolated with TRIzol Reagent (Invitrogen,
Carlsbad, California, USA) and quantified by spectrophotometry
at 260 nm. On a GeneAmpH PCR System 9700 thermocycler
(Applied Biosystems, Foster City, CA, USA), 5 mg of each total
RNA was reverse transcribed with SuperScript III (Invitrogen) at
55uC for 1 hour into total complementary DNA, which was used
as the template for the subsequent PCR reactions and analysis.
The PCR reactions involved an initial denaturation at 94uC for
5 minutes, followed by 25 or 30 cycles at 94uC for 30 seconds,
exposure to an appropriate annealing temperature (58–62uC) for
30 seconds, and then a final incubation at 72uC for 45 seconds.
The PCR primers for analysis of mRNA were: Glyceraldehyde-
3-phosphate dehydrogenase (GAPDH), sense (59-AGCCG-
CATCTTCTTTTGCGTC-39) and antisense (59-TCATATT-
TGGCAGGTTTTTCT-39);
Oct-4, sense (59-CGCACCACTGGCATTGTCAT-39)
and antisense (59-TTCTCCTTGATGTCACGCAC-39);
Nanog, sense (59-AATACCTCAGCCTCCAGCAGATG-39)
and antisense (59-CTGCGTCACACCATTGCTATTCT-39);
SOX2, sense (59-GGCAGCTACGCATGATGCAGGAGC-39)
and antisense (59-CTGGTCATGGAGTTGTACTGCACG-
39). Amplified RT-PCR products were then analyzed on 1%
agarose gels and visualized using ethidium bromide staining and a
camera system (Transilluminator/SPOT; Diagnostic Instruments,
Sterling Heights, MI, USA). The gel images of the RT–PCR
products were directly scanned (ONEDscan 1-D Gel Analysis
Software; Scanalytic Inc. Fairfax, VA, USA), and the relative
densities were obtained by determining the ratio of the signal
intensity to the GAPDH band. Gene expression between the test
(cyclosporine A treated) and the control groups was compared.
Western blotting
Whole cell lysates were separated by electrophoresis on 12%
SDS–PAGE and transferred to polyvinylidene fluoride membrane.
The membranes were blocked with 5% nonfat milk at room
temperature for 1 h. The primary antibodies were used: GAPDH
(ab9482; 1:5000 dilution) (Abcam, Cambridge, MA, USA), Oct-3/
4 (sc-8630; 1:1000), NANOG (sc-81961; 1:1000) and SOX2 (sc-
17320; 1:500) (Santa Cruz Biotechnology) in TBST buffer
containing 3% nonfat milk at 4uC overnight and subsequently
with anti-mouse and rabbit anti-goat secondary antibody conju-
gated with peroxidase (1:1000) (Santa Cruz Biotechnology) at
25uC for 1 h. The immunoblots were developed using an
enhanced chemiluminescence system, and the luminescence was
visualized on X-ray film.
Immunofluorescence
The living cells and spheres were fixed in 4% paraformalde-
hyde, permeabilized in 0.1% Triton X-100, and blocked in 5%
normal goat serum- PBS. Cells were incubated with primary
antibodies, Oct-3/4 (sc-8630, 1:200), NANOG (sc-81961,1:200),
SOX2 (sc-17320; 1:500) (Santa Cruz Biotechnology), CD133
(clone C24B9,1:200) (Cell Signaling Technology) and ALDH1
(clone 44, 1:200) (BD Biosciences, San Jose, CA, USA) washed
thrice in PBS, and then incubated with goat anti-mouse or
secondary antibodies conjugated with FITC (green) or PE (red).
The DAPI was used as nuclear stain (blue). Images were obtained
using fluorescent microscopy and a digital camera.
Chemosensitivity and radiosensitivity assay
Cells were seeding in 10 cm dish at a density of 1610
6 cells/
dish. For the chemosensitivity assay, cells were treated with 10–
200 mM Cisplatin (Sigma, St Louis, MO, USA) for 48 h. For the
radioresistance assay, cells were irradiated using a CyberKnife
radiosurgery system (Accuray, USA) to deliver different doses (2–
10 Gy). Relative survival fraction of cells was determined by MTS
assay using the CellTiter 96 Aqueous One Solution Cell
Proliferation Assay kit (Promega, Madison, WI, USA) after 36 h
of radiation treatment.
In vivo tumorigenicity study
The in vivo tumorigenicity study was performed following local
ethics committee guidelines that had full accreditation awarded by
the Association for Assessment and Accreditation of Laboratory
Animal Care in the National Defense Medical Center. Mice were
kept at 18–26uC, 30–70% humidity, and independently air-
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xenograft injection. The parental OSCC cells and spheres were
injected into the BALB/c nude mice (6 weeks). The cell suspension
(100 ml) was injected subcutaneously in each mouse with different
cell numbers from 1610
6,1 610
5,1 610
4 cells. Tumors were
formed in 7 days after injection. Tumor sizes were monitored and
measured weekly according to the formula: (length6width
2)/2. At
30 days after orthotopic inoculation, mice were euthanized under
anesthesia. All of the animals were conformed and approved by
the Institutional Animal Care and Use Committee in National
Defense Medical Center (IACUC-11-064).
Statistical analysis
The independent Student’s t test or ANOVA was used to
compare the continuous variables between groups, whereas the X
2
test was applied for the comparison of dichotomous variable. The
level of statistical significance was set at 0.05 for all tests. All
statistical analyses were performed using SPSS version 12.0 (SPSS,
Inc., Chicago, IL, USA).
Supporting Information
Figure S1 Diagrammatic illustration of the comparison
of the techniques used for the isolation of CSCs. (A)
Isolation of CSCs using surface CSC markers. (B) Alternative
option of CSC isolation via sorting of side population cells and/or
selection of chemotherapeutic-drug-resistant cells. (C) Comparison
of sphere formation in terms of time and morphology between
sphere culture using serum-free medium with growth factors
(upper panel) and sphere culture using a nonadhesive system
(lower panel).
(DOCX)
Figure S2 Comparison of the expressions of CD24 and
CD44 between parental cells and spheres. The parental
cells and spheres were either stained with a negative-control IgG
antibody (open space), (A) anti-CD24 or (B) anti-CD44 experi-
mental antibodies (solid space). (C) CD24 and CD44 were
abundantly present in both parental cells and spheres; there is
no significant difference between these two groups.
(DOCX)
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